InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Kollender Richard S, 首席财务官. Insider active across 3 companies, notably Strongbridge Biopharma plc. In total, 11 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €46k. History available since 17 May 2021. The latest transaction was disclosed on 24 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kollender Richard S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
1,681 股@ US$0.750.0012% mcap2.1% 占其流量Class A Common StockSEC:0001415666-26-000008:0
1,827 股@ US$0.750.0013% mcap2.3% 占其流量Class A Common StockSEC:0001415666-26-000008:1
14,300 股0Class A Common StockSEC:0001380106-25-000131:0
65,000 股@ US$0.771283.4% 占其流量Class A Common StockSEC:0001380106-24-000175:0
标准退出：2024年11月4日 (T+90)
14,300 股0Class A Common StockSEC:0001380106-24-000144:0
234,229 股Ordinary SharesSEC:0001179110-21-009284:0
64,791 股@ US$2.0668.3% 占其流量Ordinary SharesSEC:0001179110-21-009228:0
107,816 股@ US$0.059.0% 占其流量Class A Common StockSEC:0001104659-21-115207:0
17,088 股@ US$2.2419.1% 占其流量Ordinary SharesSEC:0001179110-21-008673:0
1,315,084 股Class A Common StockSEC:0001104659-21-094111:0
11,392 股@ US$2.2812.6% 占其流量Ordinary SharesSEC:0001179110-21-005554:0
11 条申报中的 11 条
About Kollender Richard S
Richard S. Kollender is President and CFO of Strongbridge Biopharma plc and RAPID MICRO BIOSYSTEMS, INC. In these roles, he is responsible for financial management and strategic leadership of both companies. Richard plays a key role in developing financial strategies that support growth and profitability.
